| Peroxisome proliferator-activated receptor-gamma (PPAR gamma) Pro12Ala polymorphism and colorectal cancer (CRC) risk | |
| Wang, Wei; Shao, Yan; Tang, Shenhua; Cheng, Xianyong; Lian, Haifeng; Qin, Chengyong | |
| 刊名 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
 |
| 2015 | |
| 卷号 | 8期号:3页码:4066-4072 |
| 关键词 | Colorectal cancer peroxisome proliferator-activated receptor meta-analysis polymorphism |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4766818 |
| 专题 | 山东大学 |
| 作者单位 | Binzhou Med Univ, Affiliated Hosp, Dept Gastroenterol, Binzhou 256603, Shandong, Peoples R |
| 推荐引用方式 GB/T 7714 | Wang, Wei,Shao, Yan,Tang, Shenhua,et al. Peroxisome proliferator-activated receptor-gamma (PPAR gamma) Pro12Ala polymorphism and colorectal cancer (CRC) risk[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,2015,8(3):4066-4072. |
| APA | Wang, Wei,Shao, Yan,Tang, Shenhua,Cheng, Xianyong,Lian, Haifeng,&Qin, Chengyong.(2015).Peroxisome proliferator-activated receptor-gamma (PPAR gamma) Pro12Ala polymorphism and colorectal cancer (CRC) risk.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,8(3),4066-4072. |
| MLA | Wang, Wei,et al."Peroxisome proliferator-activated receptor-gamma (PPAR gamma) Pro12Ala polymorphism and colorectal cancer (CRC) risk".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 8.3(2015):4066-4072. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论